Letter to the Editor: Proton Pump Inhibitors and Biliary Tract Cancer Risk: Causality or Reverse Causality?
Ruijie Zeng, Weihong Sha, Felix W. Leung, Hao Chen – 4 August 2021
Verifying the Benefits of Radical Treatment in Posttransplant Hepatocellular Carcinoma Oligo‐recurrence: A Propensity Score Analysis
Kin Pan Au, James Yan Yue Fung, Wing Chiu Dai, Albert Chi Yan Chan, Chung Mau Lo, Kenneth Siu Ho Chok – 4 August 2021 – This study verified whether radical treatment for hepatocellular carcinoma (HCC) oligo‐recurrence after liver transplantation conveys survival benefits. A retrospective study of 144 patients with posttransplant HCC recurrence was performed. Propensity score matching was performed to adjust for baseline covariates between patients who received radical and palliative treatments. The primary endpoint was postrecurrence survival.
Letter to the Editor: Salvage TIPS in Patients With Cirrhosis With Variceal Bleeding: MELD, Lactates, and “à la Carte” Decision
Manon Allaire, Juan Carlos Garcia‐Pagán, Aurélie Walter, Christophe Bureau, Dominique Thabut – 4 August 2021
The Multidisciplinary Management of Hepatocellular Carcinoma
Reena Salgia, Vivek Mendiratta – 4 August 2021
Management of Ostomy‐Related Varices
Zachary Henry – 4 August 2021
Management of Ostomy‐Related Varices
Zachary Henry – 4 August 2021
Artificial Intelligence in Nonalcoholic Fatty Liver Disease: A New Frontier in Diagnosis and Treatment
Pankaj Aggarwal, Naim Alkhouri – 4 August 2021
Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis
Vlad Ratziu – 4 August 2021
Direct‐Acting Antiviral Therapy and Hepatocellular Carcinoma
Nicole E. Rich, Amit G. Singal – 4 August 2021
Enhancing Electronic Health Systems to End Transmission of Chronic Hepatitis B During COVID‐19: A Collaborative Approach
Eric Chak, Fresnia Vu, Julie Dang, Ulissa Smith, Susan Stewart, Karman Tam, Amy Beste‐Fong, Breanna Phelps, Ian Johnson, Miguel Suarez, Mary Pat Pauly, Moon S. Chen – 4 August 2021